by Sarah Weatherby | Apr 24, 2020 | Uncategorized
The continued availability of medicines is one of the most important priorities for EU authorities during the COVID-19 pandemic. As such the The European Medicines Agency has provided guidance on Addressing Supply Chain Shortages Due to the COVID-19 Pandemic.... Read more by Sarah Weatherby | Apr 16, 2020 | Uncategorized
The impact of the Covid-19 pandemic on GxP supply chains and the lockdown measures mandated by the UK government and devolved bodies have resulted in restrictions in movement and the ability to visit supplier sites. This presents significant logistical difficulties in... Read more
